Profilomic Overview

  • Founded
  • 2010

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Profilomic General Information

Description

Provider of biomarker discovery services intended for research in chemical analysis, metabolomics, and lipidomics. The company uses liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) and through its databases, software and statistical analysis tools can meet all biomarker research requests, enabling physicians to characterize small organic molecules in the areas of health, environment, and food.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Business/Productivity Software
Other Healthcare Services
Primary Office
  • 31 rue d'Aguesseau
  • 92100 Boulogne Billancourt
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Profilomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-Mar-2017 000.00 Completed Generating Revenue
3. Angel (individual) 07-Jan-2016 000.00 000.00 00000 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Spin-Off 01-Jan-2010 Completed Startup
To view Profilomic’s complete valuation and funding history, request access »

Profilomic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 000.000000 000.00 000.00 00 000.00 00.000
To view Profilomic’s complete cap table history, request access »

Profilomic Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Commissariat à l'Energie Atomique Government 000 0000 000000 0
IncubAlliance Accelerator/Incubator 000 0000 000000 0
To view Profilomic’s complete investors history, request access »